We are live on ! Find out more
Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 37.72%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
-15.77%
1 Year Est. Return
+37.72%
3 Year Est. Return
+117.83%
5 Year Est. Return
+153.46%
10 Year Est. Return
+660.32%
AUM
$145B
AUM Growth
-$62.1B
Cap. Flow
-$26.6B
Cap. Flow %
-18.35%
Top 10 Hldgs %
24.48%
Holding
2,771
New
132
Increased
720
Reduced
1,519
Closed
181

Top Buys

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$541M
2
TEAM icon
Atlassian
TEAM
+$452M
3
TJX icon
TJX Companies
TJX
+$288M
4
CTVA icon
Corteva
CTVA
+$213M
5
JPM icon
JPMorgan Chase
JPM
+$179M

Sector Composition

Rank Sector Weight
1 Technology 30.37%
2 Healthcare 21.1%
3 Financials 10.49%
4 Consumer Discretionary 10.11%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMCI icon
701
Treace Medical Concepts
TMCI
$260M
$9.53M 0.01%
664,651
-1,761
-0.3% -$29.7K
OLLI icon
702
Ollie's Bargain Outlet
OLLI
$4.17B
$9.51M 0.01%
161,904
+143,765
+793% +$7.27M
BALL icon
703
Ball Corp
BALL
$17.8B
$9.51M 0.01%
138,292
-57,869
-30% -$4.39M
LBTYA icon
704
Liberty Global Class A
LBTYA
$3.49B
$9.46M 0.01%
449,327
+424,927
+1,742% +$9.97M
BDX icon
705
Becton Dickinson
BDX
$45.8B
$9.37M 0.01%
37,984
-78,171
-67% -$19.8M
FDMT icon
706
4D Molecular Therapeutics
FDMT
$515M
$9.32M 0.01%
1,335,048
-330,363
-20% -$3.21M
CM icon
707
Canadian Imperial Bank of Commerce
CM
$109B
$9.31M 0.01%
192,084
+32,612
+20% +$1.78M
KDP icon
708
Keurig Dr Pepper
KDP
$42.3B
$9.27M 0.01%
261,917
+110,080
+72% +$4M
F icon
709
Ford
F
$59.6B
$9.25M 0.01%
830,993
-1,315,114
-61% -$18M
PHAT icon
710
Phathom Pharmaceuticals
PHAT
$930M
$9.22M 0.01%
1,092,212
-909,230
-45% -$9.35M
STEM icon
711
Stem
STEM
$47.7M
$9.2M 0.01%
64,231
-17,700
-22% -$2.94M
EPIX
712
DELISTED
ESSA Pharma
EPIX
$9.17M 0.01%
2,909,410
-563,390
-16% -$3.15M
THR
713
DELISTED
Thermon Group Holdings
THR
$9.1M 0.01%
647,293
-294,790
-31% -$4.55M
ACC
714
DELISTED
American Campus Communities, Inc.
ACC
$8.96M 0.01%
138,972
-123,640
-47% -$7.83M
Y
715
DELISTED
Alleghany Corp
Y
$8.84M 0.01%
10,604
+7,157
+208% +$5.99M
BNS icon
716
Scotiabank
BNS
$108B
$8.8M 0.01%
149,110
-442,140
-75% -$28.7M
CMPX icon
717
Compass Therapeutics
CMPX
$367M
$8.8M 0.01%
3,347,171
+153,877
+5% +$334K
CSX icon
718
CSX Corp
CSX
$94.2B
$8.7M 0.01%
299,023
-293,343
-50% -$9.56M
HEI.A icon
719
HEICO Corp Class A
HEI.A
$36.8B
$8.68M 0.01%
82,443
+64,057
+348% +$7.37M
MO icon
720
Altria Group
MO
$125B
$8.65M 0.01%
207,055
-122,908
-37% -$6.36M
RYTM icon
721
Rhythm Pharmaceuticals
RYTM
$7.41B
$8.63M 0.01%
2,080,077
-870,925
-30% -$4.77M
USB icon
722
US Bancorp
USB
$100B
$8.55M 0.01%
185,675
-73,768
-28% -$3.68M
CAG icon
723
Conagra Brands
CAG
$7.38B
$8.52M 0.01%
248,874
-1,511,999
-86% -$51.5M
NEO icon
724
NeoGenomics
NEO
$1.74B
$8.52M 0.01%
1,045,692
-3,239,416
-76% -$30.9M
PPL
725
PPL Corp
PPL
$27.3B
$8.5M 0.01%
313,230
+167,530
+115% +$4.81M

Similar funds

Janus Henderson Group's Q2 2022 Portfolio in Review

As of Q2 2022, Janus Henderson Group held 2,771 positions worth $145B, down 30% from $207B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Janus Henderson Group withdrew a net $26.6B in Q2 2022, closing 181 positions and reducing 1,519 holdings. Its most notable exit was Cerner Corp, an estimated $139M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Janus Henderson Group opened a new position in Zai Lab worth $66.4M.

  • Janus Henderson Group's largest Q2 2022 buy was Zai Lab: 1,913,144 shares worth $66.4M.
  • Janus Henderson Group added most to Workday in Q2 2022, an estimated $541M increase.
  • Janus Henderson Group's biggest Q2 2022 reduction was Apple, cutting an estimated $2.7B.
  • Janus Henderson Group fully exited Cerner Corp in Q2 2022, selling an estimated $139M.
  • Janus Henderson Group's ten largest holdings make up 24% of its $145B portfolio in Q2 2022.
  • Janus Henderson Group opened 132 new positions and closed 181 in Q2 2022.
  • Janus Henderson Group's portfolio value fell 30% quarter-over-quarter to $145B.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.